Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The goal of this clinical research study is to learn if adding the combination of abiraterone acetate and prednisone with or without enzalutamide to hormonal therapy can help to control prostate cancer when given before surgery. The safety of the drug combination will also be studied.
Epistemonikos ID: 4bb421ff8c26823bf5525691627b8e7ff9a599a0
First added on: May 11, 2024